推进 COVID-19 期间妊娠研究：美国错失的机会和动力。
Advancing research in pregnancy during COVID-19: Missed opportunities and momentum in the US.
机构信息
Center for Bioethics, Department of Social Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
出版信息
Med. 2021 May 14;2(5):460-464. doi: 10.1016/j.medj.2021.04.019.
Abstract
Pregnant people's exclusion from COVID-19 vaccine research highlights both the harms of excluding pregnant people from clinical trials and the growing public support for their equitable inclusion. Protectionary tendencies must be challenged for the sake of progress. The COVID-19 pandemic presents an opportunity to translate recognition of an unjust paradigm into action.
摘要
将孕妇排除在 COVID-19 疫苗研究之外，这既凸显了将孕妇排除在临床试验之外的危害，也凸显了公众越来越支持公平纳入他们的呼声。为了取得进步，必须挑战保护主义倾向。COVID-19 大流行提供了一个将对不公正模式的认识转化为行动的机会。
相似文献
1
Advancing research in pregnancy during COVID-19: Missed opportunities and momentum in the US.推进 COVID-19 期间妊娠研究：美国错失的机会和动力。
Med. 2021 May 14;2(5):460-464. doi: 10.1016/j.medj.2021.04.019.
2
COVID-19 vaccines: Considering sex differences in efficacy and safety.新冠疫苗：考虑疗效和安全性方面的性别差异。
Contemp Clin Trials. 2022 Apr;115:106700. doi: 10.1016/j.cct.2022.106700. Epub 2022 Feb 8.
3
Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials.临床试验中 SARS-CoV-2 疫苗的免疫原性和安全性。
Front Biosci (Landmark Ed). 2021 Nov 30;26(11):1286-1304. doi: 10.52586/5024.
4
Changes in prenatal care and vaccine willingness among pregnant women during the COVID-19 pandemic.COVID-19 大流行期间孕妇产前护理和疫苗接种意愿的变化。
BMC Pregnancy Childbirth. 2022 Jul 13;22(1):558. doi: 10.1186/s12884-022-04882-x.
5
Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.BNT162b2疫苗接种者中SARS-CoV-2感染和新冠肺炎的早期感染率降低情况。
Lancet. 2021 Mar 6;397(10277):875-877. doi: 10.1016/S0140-6736(21)00448-7. Epub 2021 Feb 18.
6
Exclusion of pregnant and lactating women from COVID-19 vaccine trials: a missed opportunity.将孕妇和哺乳期妇女排除在新冠病毒疫苗试验之外：错失的机会。
Eur Heart J. 2021 Jul 21;42(28):2724-2726. doi: 10.1093/eurheartj/ehab103.
7
Pandemic Vaccines: How Are We Going to Be Better Prepared Next Time?大流行疫苗：我们下次如何更好地做准备？
Med. 2020 Dec 18;1(1):28-32. doi: 10.1016/j.medj.2020.11.004. Epub 2020 Dec 5.
8
[COVID-19: Warp Speed vaccines].[新冠疫情：极速疫苗]
Med Sci (Paris). 2021 Aug-Sep;37(8-9):759-772. doi: 10.1051/medsci/2021094. Epub 2021 Jun 3.
9
A review of approved COVID-19 vaccines.新冠病毒疫苗批准情况综述。
Rocz Panstw Zakl Hig. 2021;72(3):245-252. doi: 10.32394/rpzh.2021.0177.
10
COVID-19 vaccines: the pandemic will not end overnight.新冠疫苗：大流行不会一夜之间结束。
Lancet Microbe. 2021 Jan;2(1):e1. doi: 10.1016/S2666-5247(20)30226-3. Epub 2020 Dec 18.
引用本文的文献
1
Factors influencing the participation of pregnant and lactating women in clinical trials: A mixed-methods systematic review.影响孕妇和哺乳期妇女参与临床试验的因素：一项混合方法系统评价。
PLoS Med. 2024 May 30;21(5):e1004405. doi: 10.1371/journal.pmed.1004405. eCollection 2024 May.
2
Mothers' Impressions and Beliefs About Taking a Booster Dose for COVID-19 Vaccine During Pregnancy and Lactation.母亲们对在孕期和哺乳期接种新冠病毒疫苗加强针的看法和信念
Cureus. 2022 Dec 15;14(12):e32561. doi: 10.7759/cureus.32561. eCollection 2022 Dec.
3
Editorial: Exploring Maternal-Fetal Pharmacology Through PBPK Modeling Approaches.社论：通过生理药代动力学（PBPK）建模方法探索母胎药理学
Front Pediatr. 2022 May 18;10:880402. doi: 10.3389/fped.2022.880402. eCollection 2022.
本文引用的文献
1
Prioritization of pregnant individuals in state plans for coronavirus disease 2019 vaccination.2019冠状病毒病疫苗接种州计划中孕妇的优先排序。
Am J Obstet Gynecol. 2021 Jul;225(1):95-99. doi: 10.1016/j.ajog.2021.03.015. Epub 2021 Mar 13.
2
The Costs of Contradictory Messages About Live Vaccines in Pregnancy.关于孕期活疫苗矛盾信息的代价。
Am J Public Health. 2021 Mar;111(3):498-503. doi: 10.2105/AJPH.2020.306045. Epub 2021 Jan 21.
3
Inclusion of pregnant women in COVID-19 treatment trials: a review and global call to action.将孕妇纳入 COVID-19 治疗试验：综述与全球行动呼吁。
Lancet Glob Health. 2021 Mar;9(3):e366-e371. doi: 10.1016/S2214-109X(20)30484-8. Epub 2020 Dec 16.
4
Evaluating the National Institutes of Health's Sex as a Biological Variable Policy: Conflicting Accounts from the Front Lines of Animal Research.评估美国国立卫生研究院将性别作为生物变量的政策：来自动物研究前线的相互矛盾的说法。
J Womens Health (Larchmt). 2021 Mar;30(3):348-354. doi: 10.1089/jwh.2020.8674. Epub 2020 Nov 18.
5
Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-October 3, 2020.更新：2020 年 1 月 22 日至 10 月 3 日，美国按妊娠状况划分的有症状育龄期女性中经实验室确认感染 SARS-CoV-2 的特征。
MMWR Morb Mortal Wkly Rep. 2020 Nov 6;69(44):1641-1647. doi: 10.15585/mmwr.mm6944e3.
6
Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-June 7, 2020.美国 2020 年 1 月 22 日-6 月 7 日，按妊娠状况划分的实验室确诊感染 SARS-CoV-2 的育龄期妇女特征。
MMWR Morb Mortal Wkly Rep. 2020 Jun 26;69(25):769-775. doi: 10.15585/mmwr.mm6925a1.
7
Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response.孕妇与新兴传染病威胁疫苗：备灾、研究和应对的伦理指导
Vaccine. 2021 Jan 3;39(1):85-120. doi: 10.1016/j.vaccine.2019.01.011. Epub 2019 May 3.
8
Prescription and Other Medication Use in Pregnancy.孕期用药情况。
Obstet Gynecol. 2018 May;131(5):789-798. doi: 10.1097/AOG.0000000000002579.
9
Women's views about participating in research while pregnant.女性对于孕期参与研究的看法。
IRB. 2012 Jul-Aug;34(4):1-8.
10
Evolving knowledge of the teratogenicity of medications in human pregnancy.在人类妊娠中药物致畸性的知识不断发展。
Am J Med Genet C Semin Med Genet. 2011 Aug 15;157C(3):175-82. doi: 10.1002/ajmg.c.30313. Epub 2011 Jul 15.
Zotero 插件